Becton Dickinson & Co. (NYSE:BDX) is still on the hook for the more than $352 million it owes Retractable Technologies (NYSE:RVP) in their war over safety syringe technology, but a federal judge ruled this week that BD can delay notifying end users about its false advertising for pre-filled syringes.
Judge Leonard Davis of the U.S. District Court for Eastern Texas issued his final ruling in the case yesterday, finding that “BD attempted to monopolize the safety syringe market” and “committed false advertising under the Lanham Act,” according to court documents. Davis ordered the Franklin Lakes, N.J.-based medical device maker to pony up more than $352.2 million in damages, including more than $11.7 million in attorneys’ fees, plus pre- and post-judgment interest and costs, according to the documents.
Help employers find you! Check out all the jobs and post your resume.
